Different types of centrally acting antihypertensives and their targets in the central nervous system

P. A. van Zwieten, J. P. Chalmers

Research output: Contribution to journalReview article

42 Citations (Scopus)

Abstract

The central regulation of blood pressure and other cardiovascular parameters may involve the baroreceptor reflex arc, including both adrenergic and serotonergic pathways, as well as amino acids, as neurotransmitters. Both adrenergic and serotonergic pathways have been recognized as targets for clinically relevant, centrally acting antihypertensives, such as clonidine, guanfacine, and α-methyl-DOPA. The central components of the hybrid drugs urapidil and ketanserin also involve serotonergic pathways and receptors. For urapidil the stimulation of 5-HT1A-receptors is assumed to induce peripheral sympathoinhibition, whereas for ketanserin the central mechanism is unknown in detail. More recently central imidazoline (I1) receptors have been proposed as the major target for the newer antihypertensives rilmenidine and moxonidine. Clonidine, however, is assumed to be mixed I1- and alpha2-receptor agonist. The distinction between central I1- and alpha2-receptors may potentially offer the design of new antihypertensives, acting like clonidine but with fewer side effects. Finally, the amino acid pathways should be considered as potential targets for centrally acting antihypertensives. Experimental compounds on this basis are available but clinical implications appear to be very remote. In the present survey an outline is given of the various pathways, neurotransmitters, and receptors involved in the central regulation of blood pressure. The different types of centrally acting antihypertensives are subsequently discussed on this basis.

Original languageEnglish
Pages (from-to)787-799
Number of pages13
JournalCARDIOVASCULAR DRUGS AND THERAPY
Volume8
DOIs
Publication statusPublished - Dec 1994
Externally publishedYes

Keywords

  • centrally acting antihypertensives
  • imidazoline receptors
  • moxonidine
  • rilmenidine
  • serotonergic pathways

Fingerprint Dive into the research topics of 'Different types of centrally acting antihypertensives and their targets in the central nervous system'. Together they form a unique fingerprint.

  • Cite this